WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+17.78%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$9.17B
AUM Growth
+$646M
(+7.6%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
726
New
146
Increased
136
Reduced
152
Closed
261
Top Buys
| 1 |
TE Connectivity
TEL
|
+$118M |
| 2 |
Ovintiv
OVV
|
+$108M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$106M |
| 4 |
Amazon
AMZN
|
+$86M |
| 5 |
Qorvo
QRVO
|
+$80.1M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$238M |
| 2 |
Electronic Arts
EA
|
+$107M |
| 3 |
Autodesk
ADSK
|
+$95.8M |
| 4 |
Keysight
KEYS
|
+$88.3M |
| 5 |
STMicroelectronics
STM
|
+$82.2M |
Sector Composition
| 1 | Healthcare | 41.58% |
| 2 | Technology | 23.85% |
| 3 | Industrials | 10.4% |
| 4 | Energy | 8.49% |
| 5 | Consumer Discretionary | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Fastly
FSLY
$1.08B
| $3.21M | 0.03% |
180,518
+74,985
| +71% | +$1.33M |
|
352
Lyra Therapeutics
LYRA
$10.4M
| $3.14M | 0.03% |
+12,000
| New | +$3.14M |
|
353
CRISPR Therapeutics
CRSP
$4.78B
| $3.13M | 0.03% |
50,033
-50,379
| -50% | -$3.15M |
|
354
FIVE9
FIVN
$1.97B
| $3.02M | 0.03% |
38,344
-60,389
| -61% | -$4.75M |
|
355
EverCommerce
EVCM
$2.05B
| $2.97M | 0.03% |
268,972
-46,635
| -15% | -$514K |
|
|
ACCD
356
DELISTED
Accolade, Inc. Common Stock
ACCD
| $2.89M | 0.03% |
240,829
-934,963
| -80% | -$11.2M |
|
357
European Wax Center
EWCZ
$157M
| $2.84M | 0.03% |
+208,816
| New | +$2.84M |
|
358
Sana Biotechnology
SANA
$736M
| $2.79M | 0.03% |
684,194
+330,866
| +94% | +$1.35M |
|
359
Relay Therapeutics
RLAY
$693M
| $2.75M | 0.03% |
250,000
| – | – |
|
|
EMO
360
ClearBridge Energy Midstream Opportunity Fund
EMO
$873M
| $2.71M | 0.03% |
77,679
-265,252
| -77% | -$9.26M |
|
361
Nike
NKE
$109B
| $2.57M | 0.03% |
+23,637
| New | +$2.57M |
|
362
Kymera Therapeutics
KYMR
$3.14B
| $2.57M | 0.03% |
100,751
-2,438
| -2% | -$62.1K |
|
363
Vor Biopharma
VOR
$229M
| $2.5M | 0.03% |
1,111,123
| – | – |
|
364
Replimune Group
REPL
$453M
| $2.48M | 0.03% |
293,622
| – | – |
|
365
Boeing
BA
$172B
| $2.46M | 0.03% |
9,427
-51,236
| -84% | -$13.4M |
|
366
Perrigo
PRGO
$3.05B
| $2.44M | 0.03% |
75,819
| – | – |
|
367
Owens Corning
OC
$12.8B
| $2.33M | 0.03% |
15,700
-60,247
| -79% | -$8.93M |
|
368
Pliant Therapeutics
PLRX
$105M
| $2.25M | 0.02% |
124,090
-312,162
| -72% | -$5.65M |
|
369
TopBuild
BLD
$11.8B
| $2.2M | 0.02% |
+5,870
| New | +$2.2M |
|
|
FUSN
370
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.14M | 0.02% |
222,462
+144,427
| +185% | +$1.39M |
|
371
Semtech
SMTC
$5.38B
| $2.05M | 0.02% |
+93,582
| New | +$2.05M |
|
372
Hamilton Insurance Group
HG
$2.35B
| $2.05M | 0.02% |
+137,000
| New | +$2.05M |
|
373
Ascendis Pharma
ASND
$11.9B
| $2.03M | 0.02% |
+16,149
| New | +$2.03M |
|
374
Jamf
JAMF
$1.28B
| $1.97M | 0.02% |
109,289
-479,285
| -81% | -$8.66M |
|
375
Erasca
ERAS
$445M
| $1.96M | 0.02% |
919,119
+795,546
| +644% | +$1.69M |
|